Belladonna Sulfadiazine Tablets - Global Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Pharma & Healthcare > Belladonna Sulfadiazine Tablets - Global Top Players Market Share and Ranking 2025

Belladonna Sulfadiazine Tablets - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-12-12
Report Id: 2862800
Industry: Pharma & Healthcare
Report Page: 95
Chart: 99

PDF Download

Publication Date: 2025-12-12
Report Id: 2862800
Industry: Pharma & Healthcare
Report Page: 95
Chart: 99

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Belladonna Sulfadiazine Tablets Definition
1.2 Global Belladonna Sulfadiazine Tablets Market Size and Forecast
1.3 China Belladonna Sulfadiazine Tablets Market Size and Forecast
1.4 Share of China Belladonna Sulfadiazine Tablets Market with Respect to the Global Market
1.5 Belladonna Sulfadiazine Tablets Market Size: China VS Global Growth Rate, 2020-2031
1.6 Belladonna Sulfadiazine Tablets Market Dynamics
1.6.1 Belladonna Sulfadiazine Tablets Market Drivers
1.6.2 Belladonna Sulfadiazine Tablets Market Restraints
1.6.3 Belladonna Sulfadiazine Tablets Industry Trends
1.6.4 Belladonna Sulfadiazine Tablets Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Belladonna Sulfadiazine Tablets, Global Market Share by Company, 2020-2025
2.2 Global Belladonna Sulfadiazine Tablets Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Belladonna Sulfadiazine Tablets Concentration Ratio
2.4 Global Belladonna Sulfadiazine Tablets Mergers & Acquisitions, Expansion Plans
2.5 Global Belladonna Sulfadiazine Tablets Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Belladonna Sulfadiazine Tablets, China Market Share by Company, 2020-2025
3.2 China Belladonna Sulfadiazine Tablets Belladonna Sulfadiazine Tablets Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Belladonna Sulfadiazine Tablets Industry Chain
4.2 Belladonna Sulfadiazine Tablets Upstream Analysis
4.2.1 Belladonna Sulfadiazine Tablets Core Raw Materials
4.2.2 Main Manufacturers of Belladonna Sulfadiazine Tablets Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Belladonna Sulfadiazine Tablets Production Mode
4.6 Belladonna Sulfadiazine Tablets Procurement Model
4.7 Belladonna Sulfadiazine Tablets Industry Sales Model and Sales Channels
4.7.1 Belladonna Sulfadiazine Tablets Sales Model
4.7.2 Belladonna Sulfadiazine Tablets Typical Distributors

5 Sights by Type
5.1 Belladonna Sulfadiazine Tablets Classification by Type
5.1.1 Regular Tablets
5.1.2 Sustained-Release Tablets
5.1.3 Others
5.2 by Type, Global Belladonna Sulfadiazine Tablets Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Belladonna Sulfadiazine Tablets Consumption Value, 2020-2031

6 Sights by Pharmacological Effects
6.1 Belladonna Sulfadiazine Tablets Classification by Pharmacological Effects
6.1.1 Analgesics
6.1.2 Anti-Infectives
6.2 by Pharmacological Effects, Global Belladonna Sulfadiazine Tablets Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Pharmacological Effects, Global Belladonna Sulfadiazine Tablets Consumption Value, 2020-2031

7 Sights by Dosage Form
7.1 Belladonna Sulfadiazine Tablets Classification by Dosage Form
7.1.1 Oral Tablets
7.1.2 Compound Preparation
7.2 by Dosage Form, Global Belladonna Sulfadiazine Tablets Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Dosage Form, Global Belladonna Sulfadiazine Tablets Consumption Value, 2020-2031

8 Sights by Application
8.1 Belladonna Sulfadiazine Tablets Segment by Application
8.1.1 Hospital
8.1.2 Clinic
8.1.3 Others
8.2 by Application, Global Belladonna Sulfadiazine Tablets Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Application, Global Belladonna Sulfadiazine Tablets Consumption Value, 2020-2031

9 Sales Sights by Region
9.1 By Region, Global Belladonna Sulfadiazine Tablets Consumption Value, 2020 VS 2024 VS 2031
9.2 By Region, Global Belladonna Sulfadiazine Tablets Consumption Value, 2020-2031
9.3 North America
9.3.1 North America Belladonna Sulfadiazine Tablets Market Size & Forecasts, 2020-2031
9.3.2 By Country, North America Belladonna Sulfadiazine Tablets Market Size Market Share
9.4 Europe
9.4.1 Europe Belladonna Sulfadiazine Tablets Market Size & Forecasts, 2020-2031
9.4.2 By Country, Europe Belladonna Sulfadiazine Tablets Market Size Market Share
9.5 Asia Pacific
9.5.1 Asia Pacific Belladonna Sulfadiazine Tablets Market Size & Forecasts, 2020-2031
9.5.2 By Country/Region, Asia Pacific Belladonna Sulfadiazine Tablets Market Size Market Share
9.6 South America
9.6.1 South AmericaBelladonna Sulfadiazine Tablets Market Size & Forecasts, 2020-2031
9.6.2 By Country, South America Belladonna Sulfadiazine Tablets Market Size Market Share
9.7 Middle East & Africa

10 Sales Sights by Country Level
10.1 By Country, Global Belladonna Sulfadiazine Tablets Market Size & CAGR, 2020 VS 2024 VS 2031
10.2 By Country, Global Belladonna Sulfadiazine Tablets Consumption Value, 2020-2031
10.3 United States
10.3.1 United States Belladonna Sulfadiazine Tablets Market Size, 2020-2031
10.3.2 by Type, United States Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.3.3 by Application, United States Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.4 Europe
10.4.1 Europe Belladonna Sulfadiazine Tablets Market Size, 2020-2031
10.4.2 by Type, Europe Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.4.3 by Application, Europe Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.5 China
10.5.1 China Belladonna Sulfadiazine Tablets Market Size, 2020-2031
10.5.2 by Type, China Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.5.3 by Application, China Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.6 Japan
10.6.1 Japan Belladonna Sulfadiazine Tablets Market Size, 2020-2031
10.6.2 by Type, Japan Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.6.3 by Application, Japan Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.7 South Korea
10.7.1 South Korea Belladonna Sulfadiazine Tablets Market Size, 2020-2031
10.7.2 by Type, South Korea Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.7.3 by Application, South Korea Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.8 Southeast Asia
10.8.1 Southeast Asia Belladonna Sulfadiazine Tablets Market Size, 2020-2031
10.8.2 by Type, Southeast Asia Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.8.3 by Application, Southeast Asia Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.9 India
10.9.1 India Belladonna Sulfadiazine Tablets Market Size, 2020-2031
10.9.2 by Type, India Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.9.3 by Application, India Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.10 Middle East & Africa
10.10.1 Middle East & Africa Belladonna Sulfadiazine Tablets Market Size, 2020-2031
10.10.2 by Type, Middle East & Africa Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031
10.10.3 by Application, Middle East & Africa Belladonna Sulfadiazine Tablets Consumption Value Market Share, 2024 VS 2031

11 Company Profile
11.1 Anhui Globe Pharmaceutical
11.1.1 Anhui Globe Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
11.1.2 Anhui Globe Pharmaceutical Company Profile and Main Business
11.1.3 Anhui Globe Pharmaceutical Belladonna Sulfadiazine Tablets Models, Specifications, and Application
11.1.4 Anhui Globe Pharmaceutical Belladonna Sulfadiazine Tablets Revenue and Gross Margin, 2020-2025
11.1.5 Anhui Globe Pharmaceutical Recent Developments
11.2 Northeast Pharmaceutical Group
11.2.1 Northeast Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position
11.2.2 Northeast Pharmaceutical Group Company Profile and Main Business
11.2.3 Northeast Pharmaceutical Group Belladonna Sulfadiazine Tablets Models, Specifications, and Application
11.2.4 Northeast Pharmaceutical Group Belladonna Sulfadiazine Tablets Revenue and Gross Margin, 2020-2025
11.2.5 Northeast Pharmaceutical Group Recent Developments
11.3 Beijing Pharmaceutical
11.3.1 Beijing Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
11.3.2 Beijing Pharmaceutical Company Profile and Main Business
11.3.3 Beijing Pharmaceutical Belladonna Sulfadiazine Tablets Models, Specifications, and Application
11.3.4 Beijing Pharmaceutical Belladonna Sulfadiazine Tablets Revenue and Gross Margin, 2020-2025
11.3.5 Beijing Pharmaceutical Recent Developments
11.4 Shanghai Xinyi Pharmaceutical Factory
11.4.1 Shanghai Xinyi Pharmaceutical Factory Company Information, Head Office, Market Area, and Industry Position
11.4.2 Shanghai Xinyi Pharmaceutical Factory Company Profile and Main Business
11.4.3 Shanghai Xinyi Pharmaceutical Factory Belladonna Sulfadiazine Tablets Models, Specifications, and Application
11.4.4 Shanghai Xinyi Pharmaceutical Factory Belladonna Sulfadiazine Tablets Revenue and Gross Margin, 2020-2025
11.4.5 Shanghai Xinyi Pharmaceutical Factory Recent Developments
11.5 Guangzhou Baiyunshan Pharmaceutical
11.5.1 Guangzhou Baiyunshan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
11.5.2 Guangzhou Baiyunshan Pharmaceutical Company Profile and Main Business
11.5.3 Guangzhou Baiyunshan Pharmaceutical Belladonna Sulfadiazine Tablets Models, Specifications, and Application
11.5.4 Guangzhou Baiyunshan Pharmaceutical Belladonna Sulfadiazine Tablets Revenue and Gross Margin, 2020-2025
11.5.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
11.6 Harbin Pharmaceutical Group
11.6.1 Harbin Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position
11.6.2 Harbin Pharmaceutical Group Company Profile and Main Business
11.6.3 Harbin Pharmaceutical Group Belladonna Sulfadiazine Tablets Models, Specifications, and Application
11.6.4 Harbin Pharmaceutical Group Belladonna Sulfadiazine Tablets Revenue and Gross Margin, 2020-2025
11.6.5 Harbin Pharmaceutical Group Recent Developments

12 Conclusion

13 Appendix
13.1 Research Methodology
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Market Estimation Model
13.4 Disclaimer

According to YH Research, the global market for Belladonna Sulfadiazine Tablets should grow from US$ 120 million in 2024 to US$ 151 million by 2031, with a CAGR of 3.4% for the period of 2025-2031.

Belladonna and Sulfabenzamide Tablets are a compound medication, primarily composed of belladonna and sulfabenzamide. Belladonna extract inhibits the parasympathetic nervous system, relieving spasms, reducing gastrointestinal secretions, and providing pain relief; sulfabenzamide is an antibacterial drug that inhibits bacterial proliferation. This medication is commonly used to treat digestive system diseases such as gastrointestinal spasms and peptic ulcers, and also has a certain antibacterial effect, helping to alleviate related symptoms caused by infection. Due to its compound nature, this drug offers multiple benefits and is suitable for the comprehensive treatment of various pathological conditions. The supply chain for Belladonna and Sulfabenzamide Tablets mainly includes upstream raw material supply (belladonna extract, sulfonamide raw materials and excipients), midstream pharmaceutical manufacturing (mixing, granulation, tableting, coating, quality inspection, and packaging), and downstream wholesale, pharmacy, and hospital sales. As this type of drug is a small-molecule generic tablet, the production technology is mature, but market competition is fierce. Midstream pharmaceutical manufacturers typically have gross profit margins in the 5%-15% range, which can reach 15%-25% for branded or proprietary formula products; capacity utilization is affected by market demand and policies, generally ranging from 60% to 80%, but can be maintained at 70%-90% if orders are stable and the product line is diverse. In 2024, the global production of Belladonna and Sulfabenzamide Tablets reached 113 million units, with an average selling price of US$1 per unit.

Belladonna Sulfadiazine Tablets

According to YH Research, the global market for Belladonna Sulfadiazine Tablets should grow from US$ 120 million in 2024 to US$ 151 million by 2031, with a CAGR of 3.4% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Atropine sulfadiazine tablets were once a commonly used small-molecule compound preparation, combining the antispasmodic effects of belladonna with the antibacterial properties of sulfonamides, used to relieve gastrointestinal spasms and infection-related symptoms. In the generic drug market, this type of product has mature technology and controllable production costs, but it faces intense price competition, the impact of centralized procurement policies, and a gradually shrinking market. Especially in recent years, due to policy adjustments and safety considerations, some regions have gradually stopped production or revoked registration certificates. Therefore, the commercial value and market prospects of atropine sulfadiazine tablets are becoming limited, increasingly becoming a historical or niche-demand drug. Its future development mainly depends on alternative innovation, specific clinical needs, and the clearing of regional inventory.

This report studies and analyses global Belladonna Sulfadiazine Tablets status and future trends, to help determine the Belladonna Sulfadiazine Tablets market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Belladonna Sulfadiazine Tablets, and provides market size (US$ million) and Year-over-Year growth, considering 2023 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Belladonna Sulfadiazine Tablets market size, history data 2019-2024, and forecast data 2025 -2030, (US$ million)
(2) Global Belladonna Sulfadiazine Tablets by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(3) China Belladonna Sulfadiazine Tablets by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(4) Global Belladonna Sulfadiazine Tablets key consuming regions, consumption value and demand structure
(5) Belladonna Sulfadiazine Tablets industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Anhui Globe Pharmaceutical
    Northeast Pharmaceutical Group
    Beijing Pharmaceutical
    Shanghai Xinyi Pharmaceutical Factory
    Guangzhou Baiyunshan Pharmaceutical
    Harbin Pharmaceutical Group

Market segment by Type, covers
    Regular Tablets
    Sustained-Release Tablets
    Others

Market segment by Application, can be divided into
    Hospital
    Clinic
    Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Belladonna Sulfadiazine Tablets product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Belladonna Sulfadiazine Tablets market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 3: China Belladonna Sulfadiazine Tablets market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 4: Belladonna Sulfadiazine Tablets industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2019-2030
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2019-2030
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2019-2030
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2019-2030
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions